Layoffs
Achillion is handing out pink slips to 20 percent of its employees and initiating an operational restructuring plan.
The news was revealed in a filing with the SEC.
ImmunoGen gave a pipeline progress report and 2017 operating results last week.
That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past.
The first of the pink slips at Sandoz’ generic-drug manufacturing facility in Broomfield, Colo. have been handed out.
Arbutus said it was undertaking the restructuring in order to better align its hepatitis B business in Warminster, Penn.
The cuts were apparently announced in late January with a WARN notice filed with the state.
Koss said affected employees will receive severance benefits and career guidance.
A tipster told BioSpace that the layoffs were initially announced by Intarcia CEO Kurt Graves on Jan. 31.
PRESS RELEASES
